Nuvation Bio Inc (NUVB)
3.205
+0.02
(+0.79%)
USD |
NYSE |
May 07, 11:36
Nuvation Bio Market Cap: 702.04M for May 7, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 696.57M |
| May 03, 2024 | 705.33M |
| May 02, 2024 | 716.28M |
| May 01, 2024 | 700.95M |
| April 30, 2024 | 654.95M |
| April 29, 2024 | 646.19M |
| April 26, 2024 | 587.04M |
| April 25, 2024 | 573.90M |
| April 24, 2024 | 582.66M |
| April 23, 2024 | 587.04M |
| April 22, 2024 | 587.04M |
| April 19, 2024 | 569.52M |
| April 18, 2024 | 565.14M |
| April 17, 2024 | 589.23M |
| April 16, 2024 | 615.52M |
| April 15, 2024 | 630.85M |
| April 12, 2024 | 650.57M |
| April 11, 2024 | 690.00M |
| April 10, 2024 | 668.09M |
| April 09, 2024 | 707.52M |
| April 08, 2024 | 707.52M |
| April 05, 2024 | 720.66M |
| April 04, 2024 | 762.28M |
| April 03, 2024 | 795.14M |
| April 02, 2024 | 755.71M |
| Date | Value |
|---|---|
| April 01, 2024 | 808.28M |
| March 28, 2024 | 797.33M |
| March 27, 2024 | 869.61M |
| March 26, 2024 | 630.85M |
| March 25, 2024 | 492.85M |
| March 22, 2024 | 506.00M |
| March 21, 2024 | 490.66M |
| March 20, 2024 | 420.57M |
| March 19, 2024 | 438.09M |
| March 18, 2024 | 495.04M |
| March 15, 2024 | 499.43M |
| March 14, 2024 | 479.71M |
| March 13, 2024 | 527.90M |
| March 12, 2024 | 510.38M |
| March 11, 2024 | 523.52M |
| March 08, 2024 | 534.47M |
| March 07, 2024 | 545.42M |
| March 06, 2024 | 523.52M |
| March 05, 2024 | 477.52M |
| March 04, 2024 | 464.38M |
| March 01, 2024 | 488.47M |
| February 29, 2024 | 409.62M |
| February 28, 2024 | 431.52M |
| February 27, 2024 | 435.90M |
| February 26, 2024 | 433.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
210.97M
Minimum
Oct 31 2023
3.171B
Maximum
Mar 19 2021
1.025B
Average
611.08M
Median
Aug 31 2022
Market Cap Benchmarks
| iBio Inc | 6.899M |
| Flora Growth Corp | 16.03M |
| Lixte Biotechnology Holdings Inc | 6.658M |
| Replimune Group Inc | 422.35M |
| ABVC BioPharma Inc | 11.09M |
Market Cap Related Metrics
| Price to Book Value | 1.160 |
| Price | 3.205 |
| Earnings Yield | -10.92% |